RIOT

#1043
Riot Platforms, Inc. - Common Stock
21.5 0 USD
+0.02%
Market Price
Settore: Finanziario
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
21.45
21.70
Intervallo Annuale
11.50
30.32
Variazione giornaliera
+1.70%
Variazione Mensile
-4.91%
Variazione di 6 mesi
+30.54%
Variazione Annuale
+59.85%
Chiusura Precedente
21.1 4
Open
21.6 8
Minimo
21.4 5
Massimo
21.7 0
Volume
1 589
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi Documents

2026

Current report, Q3 FY2026
Riot Platforms, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Riot Platforms, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Riot Platforms, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Riot Platforms, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Riot Platforms, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Riot Platforms, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Riot Platforms, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Riot Platforms, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Riot Platforms, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Riot Platforms, Inc. current report, Q1 FY2026
8-K

Riot Platforms, Inc. current report, Q1 FY2006

Full document

SEC Filing Summary: Form 8-K

Business Context and Reporting Period

Company: AspenBio Pharma, Inc. (Note: Request metadata listed "Riot Platforms, Inc.", but the filing text identifies the registrant as AspenBio Pharma, Inc.)
Filing Date: March 23, 2006
Reporting Period: Current report for events occurring on March 23, 2006.
Business Context: The registrant is a Colorado-based corporation (File No. 0-50019) headquartered in Castle Rock, CO. This filing serves to disclose the issuance of a press release regarding results of operations and financial condition.

Key Financial Metrics

The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a notification that a press release containing these details was issued on March 23, 2006, and is attached as Exhibit 99.1.

Material Changes

The filing references Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure), indicating that material information regarding the company's financial status was released to the public via a press release. Specific details on changes versus prior periods are not contained within the text of this 8-K form itself.

Guidance, Outlook, and Risks

Management Commentary: The filing confirms the release of a press release but does not summarize the content of management's commentary, guidance, or outlook.
Risks and Contingencies: No specific risks or contingencies are detailed in the body of this filing text.
Unusual Items: None explicitly described in the filing text.

Investor Verification Checklist

  • Verify the content of the press release dated March 23, 2006, referenced as Exhibit 99.1, for specific financial figures.
  • Confirm the discrepancy between the request metadata ("Riot Platforms, Inc.") and the actual registrant name in the filing ("AspenBio Pharma, Inc.").
  • Review the full text of the press release to understand the specific "Results of Operations" and "Financial Condition" disclosed under Item 2.02.
  • Check for subsequent filings to see if the press release contained forward-looking statements or guidance.

Notizie